TERC Stimulates Fatty Acid Metabolism to Promote Bladder Cancer Progression
TERC is a potential therapeutic target and biomarker in bladder cancer that undergoes m6A-mediated upregulation and remodels fatty acid metabolism by enhancing RXRA levels through nuclear export PTBP3 to promote tumor aggressiveness.
Authors
- Chen Chen (ORCID: https://orcid.org/0000-0003-3484-9443)
- Wenqiang Quan (ORCID: https://orcid.org/0000-0002-8243-8078)
- Junlu Wu (ORCID: https://orcid.org/0000-0002-6537-6936)
- Ruixin Sun (ORCID: https://orcid.org/0000-0002-2096-8946)
- Renquan Lu (ORCID: https://orcid.org/0000-0003-3291-5742)
- Yiwen Yao (ORCID: https://orcid.org/0000-0002-0375-388X)
- Ping Ji (ORCID: https://orcid.org/0000-0001-6644-7014)
- Denglong Wu (ORCID: https://orcid.org/0009-0008-0398-7337)
- Dong Li (ORCID: https://orcid.org/0000-0003-4129-2268)
- Yuting Gao (ORCID: https://orcid.org/0000-0001-9413-1156)
- Zujun Sun (ORCID: https://orcid.org/0000-0002-4094-9961)
- Ying Wu
Institutions
- Tongji University (CN)
- Shanghai Medical College of Fudan University (CN)
- Fudan University Shanghai Cancer Center (CN)
- Tongji Hospital (CN)
Publication Details
- Journal
- Cancer Research
- Published
- 2025-08-04
- DOI
- https://doi.org/10.1158/0008-5472.can-24-3439
- Citations
- 1
- Primary Topic
- Cancer, Lipids, and Metabolism
- Type
- article
- Field-Weighted Citation Impact
- 0.94